Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Medicenna Therapeutics Corp. (T.MDN) had Stock-Based Compensation of 0.62M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
-3.55M |
|
-- |
|
-- |
|
-- |
|
-3.97M |
|
-- |
|
-3.55M |
|
-3.55M |
|
-3.55M |
|
-3.55M |
|
-3.55M |
|
-3.55M |
|
-3.97M |
|
-3.96M |
|
83.41M |
|
83.41M |
|
-0.04 |
|
-0.04 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
13.10M |
|
-- |
|
-- |
|
-- |
|
5.66M |
|
7.44M |
|
7.40M |
|
7.44M |
|
83.41M |
|
| Cash Flow Statement Financials | |
-6.16M |
|
-- |
|
0.01M |
|
18.03M |
|
11.44M |
|
-6.60M |
|
|
Stock-Based Compensation |
0.62M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.01 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-6.16M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-47.68% |
|
-47.91% |
|
-27.07% |
|
-47.27% |
|
0.12 |
|
-0.07 |
|
-0.07 |
|